3Gorenc M, Kozjek NR, Strojan P. Malnutrition and cachexia in patients with head and neck cancer treated with (chemo)radiotherapy [J]. Reports of Practical Oncology & Radiotherapy, 2015 [Epub ahead of print ]. 被引量：1
4Amdt K, Grinenkoa T, Mende N, et al. CD133 is a modifier of hematopoietic progenitor frequencies but is dispensable for the maintenance of mouse hematopoietic stem cells [J]. Proc Natl Acad Sci U S A, 2013, 110(14): 5582-5587. 被引量：1
5Zhang SX, Zhang F, Feng B, et al. Hematopoietic stem cell capture and directional differentiation into vascular endothelial cells for metal stent-coated chitosan/hyaluronic acid loading CD133 antibody [J]. Tissue Eng Part A, 2015, 21(5-6): 1173-1183. 被引量：1
6Jing F, Kim HJ, Kim CH, et al. Colon cancer stem cell markers CD44 and CD133 in patients with colorectal cancer and synchronous hepatic metastases[J]. Int J Oncol, 2015, 46(4): 1582-1588. 被引量：1
7Sahlberg SH, Spiegelberg D, Glimelius B, et al. Evaluation of cancer stem cell markers CD133, CD44, CD24: association with AKT isoforms and radiation resistance in colon cancer cells [J]. PLoS One, 2014, 9(4): e94621. 被引量：1
8Liu W, Wu L, Shen XM, et al. Expression patterns of cancer stem cell markers ALDH1 and CD133 correlate with a high risk of malignant transformation of oral leukoplakia [J]. lnt J Cancer, 2013, 132 (4): 868-874. 被引量：1
9Liu TJ, Sun BC, Zhao XL, et al. CD133+ cells with cancer stem cell characteristics associates with vasculogenic mimicry in triple-negative breast cancer[J]. Oncogene, 2013, 32(5): 544-553. 被引量：1
10A1-Zoubi A, Jafar E, Jamous M, et al. Transplantation of purified autologuus leukapheresis-derived CD34+ and CD133+ stem cells for patients with chronic spinal cord injuries: long-term evaluation of safety and efficacy[J]. Cell Transplant, 2014, 23(Suppl 1): $25-34. 被引量：1
